What's new

Human medicines European public assessment report (EPAR): Imcivree, setmelanotide, Date of authorisation: 16/07/2021, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR): Imcivree, setmelanotide, Date of authorisation: 16/07/2021, Revision: 11, Status: Authorised

Mar 13, 2025 - 12:03
 0
Human medicines European public assessment report (EPAR): Imcivree, setmelanotide, Date of authorisation: 16/07/2021, Revision: 11, Status: Authorised
Human medicines European public assessment report (EPAR): Imcivree, setmelanotide, Date of authorisation: 16/07/2021, Revision: 11, Status: Authorised
Read More

Tags:

Previous Article

Unregulated advanced therapy medicinal products pose serious risks to health

Next Article

JA Solar to supply 260MW of TOPCon modules to Exel Solar

Related Posts

Human medicines European public assessment report (EPAR): Rytelo, imetelstat, Date of authorisation: 07/03/2025, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 11, 2025  0

Human medicines European public assessment report (EPAR): Cejemly, sugemalimab, Date of authorisation: 24/07/2024, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 9, 2025  0

Orphan designation: N-(2-Methoxyethyl)-6-methyl-N-[(3-methyl-2-thienyl)methyl]-2-oxo-1,2-dihydropyridine-4-carboxamide Treatment of glycogen storage disease type IV, 16/01/2025 Positive

Orphan designation: N-(2-Methoxyethyl)-6-methyl-N-[(3-m...

Feb 20, 2025  0